Core Viewpoint - Nexans has announced a share buyback program, detailing the purchase of its own shares from January 26, 2026, to January 30, 2026, as part of its ongoing strategy to manage capital and enhance shareholder value [1]. Summary by Sections Share Buyback Program - Nexans will execute a buyback program as per the announcement made on March 27, 2025, on its website [1]. - The buyback period is set from January 26, 2026, to January 30, 2026 [1]. Trading Details - A total of 8,525 shares were purchased during the buyback period, with daily transactions recorded as follows: - January 26, 2026: 1,705 shares at an average price of €127.71 - January 27, 2026: 1,705 shares at an average price of €129.79 - January 28, 2026: 1,705 shares at an average price of €129.82 - January 29, 2026: 1,705 shares at an average price of €132.68 - January 30, 2026: 1,705 shares at an average price of €132.44 [2]. Broker Information - The transactions were executed by Kepler Cheuvreux, which acted as the broker for the buyback program [2][3].

Core Viewpoint - Trifork Group AG has initiated a share buyback program aimed at repurchasing shares worth up to DKK 14.92 million (approximately EUR 2 million) from 23 December 2025 to 26 February 2026 [1][2]. Group 1: Share Buyback Program Details - The share buyback program was launched in compliance with European regulations and is set to run until 26 February 2026 [1]. - As of the latest report, Trifork has repurchased a total of 98,407 shares for a total value of DKK 9,130,238 [3]. - The average purchase price of the shares repurchased under the program is DKK 92.78 [2][3]. Group 2: Treasury Shares and Outstanding Shares - Prior to the buyback, Trifork held 219,735 treasury shares, which represented 1.1% of the share capital [2]. - Following the buyback transactions, Trifork now holds a total of 278,576 treasury shares, equating to 1.4% of the total registered shares [3]. - The total number of registered shares in Trifork is 19,744,899, leading to 19,466,323 outstanding shares after accounting for treasury shares [3]. Group 3: Employee Compensation - In week 5 of the buyback program, 5,979 shares were utilized for employee compensation, transitioning from cash payments to partial share payments [3].

Core Viewpoint - Sampo plc has been actively engaging in a share buyback program, acquiring a total of 211,286 shares on 30 January 2026, as part of a broader initiative to repurchase up to EUR 150 million worth of shares, which commenced on 6 November 2025 [1][2]. Group 1: Share Buyback Details - On 30 January 2026, Sampo plc acquired 211,286 A shares at an average price of EUR 9.42 per share across various markets [1]. - The buyback program was announced on 5 November 2025, with a maximum limit of EUR 150 million, in compliance with the Market Abuse Regulation [1]. - The buyback program is authorized by Sampo's Annual General Meeting held on 23 April 2025 [1]. Group 2: Ownership and Market Impact - Following the recent transactions, Sampo plc now owns a total of 15,079,201 A shares, which represents 0.56% of the total number of shares in the company [2]. - The shares were purchased across multiple exchanges, including AQEU, CEUX, TQEX, and XHEL, indicating a diversified approach to the buyback [1].

Core Insights - AT&T's shares rose over 10% following a strong quarterly financial report and a positive long-term growth outlook [1][2] Financial Performance - The company generated $16.6 billion in free cash flow in 2024, with expectations to exceed $21 billion by 2028 [5] - AT&T's current dividend yield stands at 4.2%, and a new $10 billion share buyback program has been approved by the board [1][5] Customer Growth - AT&T attracted 421,000 postpaid phone and 283,000 fiber subscribers in the fourth quarter [2] - The fiber convergence rate increased by 200 basis points year over year to 42%, marking the fastest annual growth since tracking began [3] Customer Retention - The postpaid churn rate was reported at less than 1%, indicating effective customer retention despite competition from rivals like Verizon and T-Mobile [4]

Core Viewpoint - The share buyback program of DKK 1,000 million has been successfully completed, with a total of 1,095,377 shares repurchased, representing 1.63% of the company's share capital [1][2]. Summary by Sections Share Buyback Program Completion - The share buyback program was executed from June 2, 2025, to January 30, 2026, totaling DKK 1,000 million [1]. - A total of 681,177 shares were purchased at an average price of DKK 1,437.97, amounting to DKK 979,512,300 under the program [2]. Transaction Details - The transactions included: - January 26, 2026: 2,500 shares at DKK 1,605.76 - January 27, 2026: 2,500 shares at DKK 1,615.45 - January 28, 2026: 2,500 shares at DKK 1,602.98 - January 29, 2026: 3,000 shares at DKK 1,598.00 - January 30, 2026: 2,400 shares at DKK 1,618.18 [2]. Total Shares and Future Plans - The total shares bought back under both the DKK 500 million and DKK 1,000 million programs will be proposed for cancellation at the bank's annual general meeting in March 2026 [1][2].

Core Viewpoint - Sampo plc has been actively engaging in a share buyback program, acquiring a total of 210,803 A shares on 29 January 2026, as part of a broader initiative announced in November 2025 to repurchase shares worth up to EUR 150 million [1][2]. Group 1: Share Buyback Details - On 29 January 2026, Sampo plc acquired 210,803 A shares at an average price of EUR 9.44 per share across various markets [1]. - The buyback volume included 8,333 shares on AQEU, 79,549 shares on CEUX, 31,275 shares on TQEX, and 91,646 shares on XHEL [1]. - The share buyback program commenced on 6 November 2025, following authorization from Sampo's Annual General Meeting on 23 April 2025 [1]. Group 2: Ownership and Market Impact - Following the recent transactions, Sampo plc now holds a total of 14,867,915 A shares, which represents 0.56% of the total shares outstanding [2]. - The buyback program is conducted in compliance with the Market Abuse Regulation (EU) 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 [1].

Group 1 - The article discusses the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1]

Core Viewpoint - Wolters Kluwer has repurchased 162,847 ordinary shares for €13.5 million at an average price of €82.69 as part of its ongoing share buyback program [1][2]. Share Buyback Program - The share buyback program was announced on November 5, 2025, with a total intended repurchase of up to €200 million from November 6, 2025, to February 23, 2026 [2]. - As of the date of the report, a cumulative total of 590,687 shares have been repurchased in 2026, amounting to €51.3 million, with an average share price of €86.79 [2]. Treasury Shares and Capital Reduction - Shares repurchased will be held as treasury shares and are intended for capital reduction through share cancellation [3]. Company Overview - Wolters Kluwer is a global leader in professional information solutions, software, and services, serving customers in over 180 countries and employing approximately 21,900 people [4][5].

Group 1 - Sampo plc has conducted share buybacks totaling 213,473 shares on 28 January 2026, with an average purchase price of EUR 9.32 per share [1] - The share buyback program, announced on 5 November 2025, has a maximum limit of EUR 150 million and is in compliance with the Market Abuse Regulation [1] - As of the latest transactions, Sampo plc owns a total of 14,657,112 A shares, representing 0.55% of the total shares outstanding [2]

Core Insights - The company reported a Q4 sales growth of 13.3% at constant exchange rates (CER) and a business earnings per share (EPS) of €1.53, reflecting strong performance driven by new medicines and Dupixent [1][2]. Sales Performance - In Q4 2025, net sales reached €11.3 billion, marking a 7.0% increase year-over-year at actual exchange rates and a 13.3% increase at CER [5]. - For the full year 2025, net sales totaled €43.6 billion, with a 6.2% increase at actual exchange rates and a 9.9% increase at CER [5]. Earnings Performance - Business EPS for Q4 2025 was €1.53, up by 16.8% at actual exchange rates and 26.7% at CER [5]. - The full year 2025 business EPS improved to €7.83, reflecting a 10.0% increase at actual exchange rates and a 15.0% increase at CER [5]. Product Developments - The company launched three new medicines and vaccines in 2025, contributing to sales growth [3]. - Dupixent sales increased by 32.2% to €4.2 billion, while pharmaceutical launches increased sales by 49.4%, reaching €1.1 billion [4]. Regulatory Approvals and R&D - The company obtained ten regulatory approvals across various therapeutic areas, including immunology and rare diseases [4]. - Research and Development expenses reached €2.3 billion, up by 6.6%, indicating continued investment in innovation [4]. Future Guidance - For 2026, the company expects sales to grow by a high single-digit percentage at CER, with business EPS anticipated to grow slightly faster than sales [2][4]. - A share buyback program of €1 billion is planned for 2026 [2]. Financial Management - The company completed a €5 billion share buyback program and proposed a dividend of €4.12, up by 5.1% [4]. - Free cash flow for Q4 2025 was €2.6 billion, reflecting a 12.7% increase [5].